| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 34.93▲ | 35.32▼ | 35.36▼ | 35.87▼ | 38.15▼ |
| MA10 | 35.05▼ | 35.53▼ | 35.87▼ | 38.27▼ | 36.25▼ |
| MA20 | 35.20▼ | 35.98▼ | 36.15▼ | 38.56▼ | 34.33▲ |
| MA50 | 35.82▼ | 37.38▼ | 38.57▼ | 35.69▼ | 30.12▲ |
| MA100 | 36.63▼ | 39.01▼ | 38.89▼ | 34.01▲ | 25.67▲ |
| MA200 | 38.75▼ | 38.06▼ | 36.81▼ | 30.60▲ | 23.79▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.005▼ | 0.010▲ | -0.754▼ | 0.028▲ |
| RSI | 41.858▼ | 36.597▼ | 32.504▼ | 41.500▼ | 53.217▲ |
| STOCH | 17.298▼ | 17.361▼ | 14.627▼ | 22.811 | 71.801 |
| WILL %R | -85.714▼ | -94.923▼ | -94.923▼ | -98.472▼ | -56.009 |
| CCI | -53.659 | -116.230▼ | -146.687▼ | -126.156▼ | -13.643 |
|
Tuesday, January 20, 2026 09:33 AM
Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and lower opioid use in a late-stage trial.
|
|
Monday, January 19, 2026 12:25 AM
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the ...
|
|
Sunday, January 18, 2026 04:31 PM
Approval Label May Include Opioid ReductionNEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/01/26 | 35.555 | 35.66 | 34.855 | 34.97 | 29,263 |
| 23/01/26 | 36.35 | 37.12 | 35.11 | 35.50 | 29,420 |
| 22/01/26 | 37.33 | 37.505 | 36.1801 | 36.52 | 20,580 |
| 21/01/26 | 36.05 | 37.3301 | 35.00 | 36.68 | 92,272 |
| 20/01/26 | 39.20 | 39.21 | 35.00 | 35.69 | 140,880 |
| 16/01/26 | 40.44 | 41.96 | 40.25 | 40.96 | 22,864 |
| 15/01/26 | 41.32 | 42.00 | 40.50 | 40.64 | 37,292 |
| 14/01/26 | 41.03 | 42.38 | 40.44 | 41.07 | 50,600 |
| 13/01/26 | 40.09 | 41.99 | 40.09 | 40.63 | 38,391 |
| 12/01/26 | 39.35 | 40.62 | 39.23 | 40.09 | 35,400 |
|
|
||||
|
|
||||
|
|